26 ANALYTICAL AND LABORATORY EQUIPMENT
Planning on exporting? Get your contracts right
Patricia Barclay reveals the legal issues surrounding the distribution of scientific products.
L
egal experts have been observing a number of problems associated
with distribution agreements in the scientific sector. Tese issues generally fall into one of three categories: the contract was unsuitable for the country of distribution; the choice of dispute resolution clause was inappropriate for the parties; or circumstances had changed and the contract no longer covered actual practice.
“Some countries even require that a certain style of contract is used. Additionally, regulated products such as pharma and medical devices may be subject to further country-specific rules.”
Problems typically arise when a single contract template is used for every country where the goods are to be distributed. Firstly, there may be issues of language. Te words “agent” and “distributor” are often used interchangeably, whereas legally they are quite different: a distributor generally buys goods and resells them at his own risk, while an agent identifies customers to whom the manufacturer sells directly, with the agent receiving a commission. Sometimes the lines may get blurred, with the distributor also taking on tasks for the manufacturer such as attending to the product registrations for pharmaceuticals or providing maintenance or product support for equipment. Tat may lead to problems if local law provides different termination rules or compensation depending on whether the local representative is deemed distributor or agent. Te distribution agreement should provide means for mitigating any termination fee.
Tere may be other local rules that mean a contract is invalid. For example, in some countries the agreement must be registered with a local agency or must be
www.scientistlive.com
written in the local language. Some countries even require that a certain style of contract is used. Additionally, regulated products such as pharma and medical devices may be subject to further country-specific rules.
Another common problem is enforcement. A standard template will often provide for dispute resolution before the courts of the manufacturer’s home country. Tis may be overridden by the laws of the distribution country. More commonly, it’s simply impractical if the countries involved do not have a treaty to enforce each other’s judgements and if the defendant does not have assets in the country of the courts then it can be very difficult to enforce that judgement. In these cases it may be better to provide for arbitration, which
is often more easily enforceable – however it is important to select a form of arbitration that is affordable for the parties and proportionate to the size of the dispute.
Finally, long-term relationships may be adjusted over time without reference to the underlying contract either in writing or just as a matter of practice and this can make it difficult if the relationship does break down to use the original contract as a basis for resolution.
Ideally you should consider local rules when setting up a distribution agreement, understand what is involved in any arbitration proposal and review your contracts regularly to ensure they reflect reality.
For more information ✔ at
www.scientistlive.com/eurolab
Patricia Barclay is a life sciences lawyer and the founder of Bonaccord, UK.
www.bonaccord.eu
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92